Log In
Print
BCIQ
Print
Print this Print this
 

NT-113

  Manage Alerts
Collapse Summary General Information
Company Kanion Pharmaceutical Co. Ltd.
DescriptionOral small molecule inhibitor of EGFR, EGFR2 (HER2; ErbB2; neu) and EGFR4 (HER4; ErbB4)
Molecular Target Epidermal growth factor receptor (EGFR) ; Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Mechanism of ActionEpidermal growth factor (EGF) receptor inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today